Please use this identifier to cite or link to this item:
Title: Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.
Issue Date: 17-Mar-2016
Citation: Stem Cell Res Ther.2016 Mar;(7):43
Abstract: Multiple sclerosis is a widespread inflammatory demyelinating disease. Several immunomodulatory therapies are available, including interferon-β, glatiramer acetate, natalizumab, fingolimod, and mitoxantrone. Although useful to delay disease progression, they do not provide a definitive cure and are associated with some undesirable side-effects. Accordingly, the search for new therapeutic methods constitutes an active investigation field. The use of mesenchymal stem cells (MSCs) to modify the disease course is currently the subject of intense interest. Decidua-derived MSCs (DMSCs) are a cell population obtained from human placental extraembryonic membranes able to differentiate into the three germ layers. This study explores the therapeutic potential of DMSCs.
PMID: 26987803
Rights: openAccess
Appears in Collections:Hospitales > H. Central de la Cruz Roja San José y Santa Adela > Artículos

Files in This Item:
File Description SizeFormat 
PMC4797118.pdf3.06 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.